Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, J.H. | - |
dc.contributor.author | Song, J.Y. | - |
dc.contributor.author | Yi, K.W. | - |
dc.contributor.author | Kim, J.J. | - |
dc.contributor.author | Hwang, K.R. | - |
dc.contributor.author | Shin, J.-H. | - |
dc.contributor.author | Lee, J.Y. | - |
dc.contributor.author | Chae, H.D. | - |
dc.date.accessioned | 2022-11-19T19:40:38Z | - |
dc.date.available | 2022-11-19T19:40:38Z | - |
dc.date.created | 2022-11-18 | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2287-8572 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/145991 | - |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic © 2022 Korean Society of Obstetrics and Gynecology | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Korean Society of Obstetrics and Gynecology | - |
dc.title | Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Yi, K.W. | - |
dc.identifier.doi | 10.5468/ogs.21322 | - |
dc.identifier.scopusid | 2-s2.0-85126968255 | - |
dc.identifier.bibliographicCitation | Obstetrics and Gynecology Science, v.65, no.2, pp.125 - 132 | - |
dc.relation.isPartOf | Obstetrics and Gynecology Science | - |
dc.citation.title | Obstetrics and Gynecology Science | - |
dc.citation.volume | 65 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 125 | - |
dc.citation.endPage | 132 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002820290 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Combined | - |
dc.subject.keywordAuthor | Contraception | - |
dc.subject.keywordAuthor | Contraceptives | - |
dc.subject.keywordAuthor | Covid-19 | - |
dc.subject.keywordAuthor | Covid-19 vaccines | - |
dc.subject.keywordAuthor | Long-acting reversible contraception | - |
dc.subject.keywordAuthor | Oral | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.